img

Global Influenza Vaccination Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Influenza Vaccination Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
Influenza Vaccination report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Influenza Vaccination market is projected to reach US$ 4872.9 million in 2034, increasing from US$ 3501.6 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2034. Demand from Hospitals and Research Organizations are the major drivers for the industry.
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Influenza Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Segment by Type
Egg Based
Cell Culture
Recombinant

Segment by Application


Hospitals
Research Organizations
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Influenza Vaccination market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Influenza Vaccination introduction, etc. Influenza Vaccination Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Influenza Vaccination market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Influenza Vaccination
1.1 Influenza Vaccination Market Overview
1.1.1 Influenza Vaccination Product Scope
1.1.2 Influenza Vaccination Market Status and Outlook
1.2 Global Influenza Vaccination Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Influenza Vaccination Market Size by Region (2024-2034)
1.4 Global Influenza Vaccination Historic Market Size by Region (2024-2024)
1.5 Global Influenza Vaccination Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Influenza Vaccination Market Size (2024-2034)
1.6.1 North America Influenza Vaccination Market Size (2024-2034)
1.6.2 Europe Influenza Vaccination Market Size (2024-2034)
1.6.3 Asia-Pacific Influenza Vaccination Market Size (2024-2034)
1.6.4 Latin America Influenza Vaccination Market Size (2024-2034)
1.6.5 Middle East & Africa Influenza Vaccination Market Size (2024-2034)
2 Influenza Vaccination Market by Type
2.1 Introduction
2.1.1 Egg Based
2.1.2 Cell Culture
2.1.3 Recombinant
2.2 Global Influenza Vaccination Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Influenza Vaccination Historic Market Size by Type (2024-2024)
2.2.2 Global Influenza Vaccination Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Influenza Vaccination Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Influenza Vaccination Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Influenza Vaccination Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Influenza Vaccination Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Influenza Vaccination Revenue Breakdown by Type (2024-2034)
3 Influenza Vaccination Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Research Organizations
3.2 Global Influenza Vaccination Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Influenza Vaccination Historic Market Size by Application (2024-2024)
3.2.2 Global Influenza Vaccination Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Influenza Vaccination Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Influenza Vaccination Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Influenza Vaccination Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Influenza Vaccination Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Influenza Vaccination Revenue Breakdown by Application (2024-2034)
4 Influenza Vaccination Competition Analysis by Players
4.1 Global Influenza Vaccination Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2022)
4.3 Date of Key Players Enter into Influenza Vaccination Market
4.4 Global Top Players Influenza Vaccination Headquarters and Area Served
4.5 Key Players Influenza Vaccination Product Solution and Service
4.6 Competitive Status
4.6.1 Influenza Vaccination Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott (U.S.)
5.1.1 Abbott (U.S.) Profile
5.1.2 Abbott (U.S.) Main Business
5.1.3 Abbott (U.S.) Influenza Vaccination Products, Services and Solutions
5.1.4 Abbott (U.S.) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.1.5 Abbott (U.S.) Recent Developments
5.2 AstraZeneca (Europe)
5.2.1 AstraZeneca (Europe) Profile
5.2.2 AstraZeneca (Europe) Main Business
5.2.3 AstraZeneca (Europe) Influenza Vaccination Products, Services and Solutions
5.2.4 AstraZeneca (Europe) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.2.5 AstraZeneca (Europe) Recent Developments
5.3 BioCryst Pharmaceuticals (U.S.)
5.3.1 BioCryst Pharmaceuticals (U.S.) Profile
5.3.2 BioCryst Pharmaceuticals (U.S.) Main Business
5.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Products, Services and Solutions
5.3.4 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.3.5 Novartis (Europe) Recent Developments
5.4 Novartis (Europe)
5.4.1 Novartis (Europe) Profile
5.4.2 Novartis (Europe) Main Business
5.4.3 Novartis (Europe) Influenza Vaccination Products, Services and Solutions
5.4.4 Novartis (Europe) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.4.5 Novartis (Europe) Recent Developments
5.5 DAIICHI SANKYO COMPANY (Asia Pacific)
5.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Profile
5.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Main Business
5.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Products, Services and Solutions
5.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments
5.6 GlaxoSmithKline (Europe)
5.6.1 GlaxoSmithKline (Europe) Profile
5.6.2 GlaxoSmithKline (Europe) Main Business
5.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Products, Services and Solutions
5.6.4 GlaxoSmithKline (Europe) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.6.5 GlaxoSmithKline (Europe) Recent Developments
5.7 Hualan Biological Engineering (Asia Pacific)
5.7.1 Hualan Biological Engineering (Asia Pacific) Profile
5.7.2 Hualan Biological Engineering (Asia Pacific) Main Business
5.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Products, Services and Solutions
5.7.4 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.7.5 Hualan Biological Engineering (Asia Pacific) Recent Developments
5.8 Mitsubishi Tanabe Pharma (Asia Pacific)
5.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Profile
5.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Main Business
5.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Products, Services and Solutions
5.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments
5.9 F. Hoffmann-La Roche (Europe)
5.9.1 F. Hoffmann-La Roche (Europe) Profile
5.9.2 F. Hoffmann-La Roche (Europe) Main Business
5.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Products, Services and Solutions
5.9.4 F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.9.5 F. Hoffmann-La Roche (Europe) Recent Developments
5.10 Sanofi (Europe)
5.10.1 Sanofi (Europe) Profile
5.10.2 Sanofi (Europe) Main Business
5.10.3 Sanofi (Europe) Influenza Vaccination Products, Services and Solutions
5.10.4 Sanofi (Europe) Influenza Vaccination Revenue (US$ Million) & (2024-2024)
5.10.5 Sanofi (Europe) Recent Developments
6 North America
6.1 North America Influenza Vaccination Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Influenza Vaccination Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccination Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Influenza Vaccination Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Influenza Vaccination Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Influenza Vaccination Market Dynamics
11.1 Influenza Vaccination Industry Trends
11.2 Influenza Vaccination Market Drivers
11.3 Influenza Vaccination Market Challenges
11.4 Influenza Vaccination Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Influenza Vaccination Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Influenza Vaccination Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Influenza Vaccination Market Size Share by Region (2024-2024)
Table 4. Global Influenza Vaccination Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Influenza Vaccination Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Influenza Vaccination Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Influenza Vaccination Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Influenza Vaccination Revenue Market Share by Type (2024-2024)
Table 9. Global Influenza Vaccination Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Influenza Vaccination Revenue Market Share by Type (2024-2034)
Table 11. North America Influenza Vaccination Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Influenza Vaccination Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Influenza Vaccination Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Influenza Vaccination Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Influenza Vaccination Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Influenza Vaccination Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Influenza Vaccination Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Influenza Vaccination Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Influenza Vaccination Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Influenza Vaccination Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Influenza Vaccination Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Influenza Vaccination Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Influenza Vaccination Revenue Market Share by Application (2024-2024)
Table 24. Global Influenza Vaccination Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Influenza Vaccination Revenue Market Share by Application (2024-2034)
Table 26. North America Influenza Vaccination Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Influenza Vaccination Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Influenza Vaccination Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Influenza Vaccination Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Influenza Vaccination Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Influenza Vaccination Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Influenza Vaccination Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Influenza Vaccination Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Influenza Vaccination Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Influenza Vaccination Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Influenza Vaccination Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Influenza Vaccination Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2022)
Table 39. Date of Key Players Enter into Influenza Vaccination Market
Table 40. Global Influenza Vaccination Key Players Headquarters and Area Served
Table 41. Influenza Vaccination Product Solution and Service
Table 42. Global Influenza Vaccination Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbott (U.S.) Basic Information List
Table 45. Abbott (U.S.) Description and Business Overview
Table 46. Abbott (U.S.) Influenza Vaccination Products, Services and Solutions
Table 47. Revenue (US$ Million) in Influenza Vaccination Business of Abbott (U.S.) (2024-2024)
Table 48. Abbott (U.S.) Recent Developments
Table 49. AstraZeneca (Europe) Basic Information List
Table 50. AstraZeneca (Europe) Description and Business Overview
Table 51. AstraZeneca (Europe) Influenza Vaccination Products, Services and Solutions
Table 52. Revenue (US$ Million) in Influenza Vaccination Business of AstraZeneca (Europe) (2024-2024)
Table 53. AstraZeneca (Europe) Recent Developments
Table 54. BioCryst Pharmaceuticals (U.S.) Basic Information List
Table 55. BioCryst Pharmaceuticals (U.S.) Description and Business Overview
Table 56. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Products, Services and Solutions
Table 57. Revenue (US$ Million) in Influenza Vaccination Business of BioCryst Pharmaceuticals (U.S.) (2024-2024)
Table 58. BioCryst Pharmaceuticals (U.S.) Recent Developments
Table 59. Novartis (Europe) Basic Information List
Table 60. Novartis (Europe) Description and Business Overview
Table 61. Novartis (Europe) Influenza Vaccination Products, Services and Solutions
Table 62. Revenue (US$ Million) in Influenza Vaccination Business of Novartis (Europe) (2024-2024)
Table 63. Novartis (Europe) Recent Developments
Table 64. DAIICHI SANKYO COMPANY (Asia Pacific) Basic Information List
Table 65. DAIICHI SANKYO COMPANY (Asia Pacific) Description and Business Overview
Table 66. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Products, Services and Solutions
Table 67. Revenue (US$ Million) in Influenza Vaccination Business of DAIICHI SANKYO COMPANY (Asia Pacific) (2024-2024)
Table 68. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments
Table 69. GlaxoSmithKline (Europe) Basic Information List
Table 70. GlaxoSmithKline (Europe) Description and Business Overview
Table 71. GlaxoSmithKline (Europe) Influenza Vaccination Products, Services and Solutions
Table 72. Revenue (US$ Million) in Influenza Vaccination Business of GlaxoSmithKline (Europe) (2024-2024)
Table 73. GlaxoSmithKline (Europe) Recent Developments
Table 74. Hualan Biological Engineering (Asia Pacific) Basic Information List
Table 75. Hualan Biological Engineering (Asia Pacific) Description and Business Overview
Table 76. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Products, Services and Solutions
Table 77. Revenue (US$ Million) in Influenza Vaccination Business of Hualan Biological Engineering (Asia Pacific) (2024-2024)
Table 78. Hualan Biological Engineering (Asia Pacific) Recent Developments
Table 79. Mitsubishi Tanabe Pharma (Asia Pacific) Basic Information List
Table 80. Mitsubishi Tanabe Pharma (Asia Pacific) Description and Business Overview
Table 81. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Products, Services and Solutions
Table 82. Revenue (US$ Million) in Influenza Vaccination Business of Mitsubishi Tanabe Pharma (Asia Pacific) (2024-2024)
Table 83. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments
Table 84. F. Hoffmann-La Roche (Europe) Basic Information List
Table 85. F. Hoffmann-La Roche (Europe) Description and Business Overview
Table 86. F. Hoffmann-La Roche (Europe) Influenza Vaccination Products, Services and Solutions
Table 87. Revenue (US$ Million) in Influenza Vaccination Business of F. Hoffmann-La Roche (Europe) (2024-2024)
Table 88. F. Hoffmann-La Roche (Europe) Recent Developments
Table 89. Sanofi (Europe) Basic Information List
Table 90. Sanofi (Europe) Description and Business Overview
Table 91. Sanofi (Europe) Influenza Vaccination Products, Services and Solutions
Table 92. Revenue (US$ Million) in Influenza Vaccination Business of Sanofi (Europe) (2024-2024)
Table 93. Sanofi (Europe) Recent Developments
Table 94. North America Influenza Vaccination Market Size by Country (2024-2024) & (US$ Million)
Table 95. North America Influenza Vaccination Market Size by Country (2024-2034) & (US$ Million)
Table 96. Europe Influenza Vaccination Market Size by Country (2024-2024) & (US$ Million)
Table 97. Europe Influenza Vaccination Market Size by Country (2024-2034) & (US$ Million)
Table 98. Asia-Pacific Influenza Vaccination Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 99. Asia-Pacific Influenza Vaccination Market Size by Region (2024-2024) & (US$ Million)
Table 100. Asia-Pacific Influenza Vaccination Market Size by Region (2024-2034) & (US$ Million)
Table 101. Asia-Pacific Influenza Vaccination Market Share by Region (2024-2024)
Table 102. Asia-Pacific Influenza Vaccination Market Share by Region (2024-2034)
Table 103. Latin America Influenza Vaccination Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 104. Latin America Influenza Vaccination Market Size by Country (2024-2024) & (US$ Million)
Table 105. Latin America Influenza Vaccination Market Size by Country (2024-2034) & (US$ Million)
Table 106. Middle East & Africa Influenza Vaccination Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 107. Middle East & Africa Influenza Vaccination Market Size by Country (2024-2024) & (US$ Million)
Table 108. Middle East & Africa Influenza Vaccination Market Size by Country (2024-2034) & (US$ Million)
Table 109. Influenza Vaccination Market Trends
Table 110. Influenza Vaccination Market Drivers
Table 111. Influenza Vaccination Market Challenges
Table 112. Influenza Vaccination Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Vaccination Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Influenza Vaccination Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Influenza Vaccination Market Share by Regions: 2022 VS 2034
Figure 4. Global Influenza Vaccination Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Influenza Vaccination Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Influenza Vaccination Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Influenza Vaccination Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Influenza Vaccination Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Influenza Vaccination Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Egg Based
Figure 11. Global Egg Based Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Cell Culture
Figure 13. Global Cell Culture Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Recombinant
Figure 15. Global Recombinant Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Influenza Vaccination Market Size Share by Type: 2022 & 2034
Figure 17. North America Influenza Vaccination Revenue Market Share by Type (2024-2034)
Figure 18. Europe Influenza Vaccination Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Influenza Vaccination Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Influenza Vaccination Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Influenza Vaccination Revenue Market Share by Type (2024-2034)
Figure 22. Hospitals Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Research Organizations Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Influenza Vaccination Market Size Share by Application: 2022 & 2034
Figure 25. North America Influenza Vaccination Revenue Market Share by Application (2024-2034)
Figure 26. Europe Influenza Vaccination Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific Influenza Vaccination Revenue Market Share by Application (2024-2034)
Figure 28. Latin America Influenza Vaccination Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa Influenza Vaccination Revenue Market Share by Application (2024-2034)
Figure 30. Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players Influenza Vaccination Market Share in 2022
Figure 32. North America Influenza Vaccination Market Share by Country (2024-2034)
Figure 33. U.S. Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 34. Canada Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 35. Germany Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 36. France Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 38. Italy Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 39. Russia Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific Influenza Vaccination Market Share by Region (2024-2034)
Figure 42. China Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 43. Japan Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 46. India Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 47. Australia Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America Influenza Vaccination Market Share by Country (2024-2034)
Figure 49. Mexico Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Influenza Vaccination Market Share by Country (2024-2034)
Figure 52. Turkey Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 54. UAE Influenza Vaccination Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries